These findings suggested that reduced expression of miR-744 by cancer cell-derived EVs enhanced the expression of SUV39H1, which further regulated Smad9/BMP4 to promote NSCLC development. The gene discussed is SUV39H1; the disease is non-small cell lung carcinoma.